--- title: "Zura Bio (ZURA) stock listing, news and investor profile" url: "https://aibio.space/companies/zura-bio/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Zura Bio Limited (NASDAQ: ZURA), United States. The directory classifies it as Biotechnology." --- ZURA Zura Bio Limited NASDAQ · United States # Zura Bio (ZURA) news Financings · 2026-01-02 ## [Zura Bio to issue 8,657,402 shares and pay $7,325,000 to Athanor Capital, ends Stone Peach deals](https://aibio.space/news/zura-bio-issue-8-657-402-shares-pay-7-325-000-athanor-capital-ends/) Zura Bio will issue 8,657,402 Class A shares to Athanor Capital and pay it a $7,325,000 upfront fee within 30 days, ending its Stone Peach and BAFFX17 arrangements. An internal audit subcommittee review found no issue that affected previously filed financial statements, and the Athanor deal adds a $25,000,000 milestone payment. ## Latest Zura Bio news 1. 2025-04-17 Financings [Zura Bio swaps shares for pre-funded warrants with Venrock affiliates and AI Biotechnology](https://aibio.space/news/zura-bio-swaps-shares-pre-funded-warrants-venrock-affiliates-ai/) Shareholders will surrender 3.5 million and 3.0 million Class A ordinary shares for no consideration and receive pre-funded warrants with a $0.001 exercise price. ## Zura Bio at a glance - **Ticker**: ZURA - **Listing**: NASDAQ - **Country**: United States - **Cash, Sep 30, 2026**: $187.7 million ### Related companies - [MeiraGTx Holdings](https://aibio.space/companies/meiragtx/) NASDAQ: MGTX - [Cadrenal Therapeutics](https://aibio.space/companies/cadrenal-therapeutics/) NASDAQ: CVKD - [Alector](https://aibio.space/companies/alector/) NASDAQ: ALEC - [Nascent Biotech](https://aibio.space/companies/nascent-biotech/) OTC: NBIO - [Seres Therapeutics](https://aibio.space/companies/seres-therapeutics/) NASDAQ: MCRB - [Statera Biopharma](https://aibio.space/companies/statera-biopharma/) OTC: STAB - [Mineralys Therapeutics](https://aibio.space/companies/mineralys-therapeutics/) NASDAQ: MLYS - [Lineage Cell Therapeutics](https://aibio.space/companies/lineage-cell-therapeutics/) AMEX: LCTX ### Also on NASDAQ - [Alzamend Neuro](https://aibio.space/companies/alzamend-neuro/) ALZN - [Nexalin Technology](https://aibio.space/companies/nexalin-technology/) NXL - [NervGen Pharma](https://aibio.space/companies/nervgen-pharma/) NGEN - [BIOMERICA INC](https://aibio.space/companies/biomerica/) BMRA - [AquaBounty Technologies](https://aibio.space/companies/aquabounty-technologies/) AQB - [Lumexa Imaging Holdings](https://aibio.space/companies/lumexa-imaging/) LMRI ## Zura Bio annual financials | Line | FY2025 | FY2024 | |---|---|---| | Research and development | [$42.1 million](https://www.sec.gov/Archives/edgar/data/1855644/000110465926032080/) | [$24.4 million](https://www.sec.gov/Archives/edgar/data/1855644/000110465926032080/) | | Net income (loss) | [-$68.7 million](https://www.sec.gov/Archives/edgar/data/1855644/000110465926032080/) | [-$52.4 million](https://www.sec.gov/Archives/edgar/data/1855644/000110465926032080/) | | Cash from operations | [-$64.8 million](https://www.sec.gov/Archives/edgar/data/1855644/000110465926032080/) | [-$28.1 million](https://www.sec.gov/Archives/edgar/data/1855644/000110465926032080/) | | Cash and equivalents | [$109.4 million](https://www.sec.gov/Archives/edgar/data/1855644/000185564426000011/) | [$176.5 million](https://www.sec.gov/Archives/edgar/data/1855644/000110465926032080/) | Latest balance sheet, Sep 30, 2026 (10-Q): cash and equivalents $187.7 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Zura Bio What is the ticker symbol of Zura Bio? Zura Bio Limited trades under the ticker ZURA on NASDAQ. Where is Zura Bio listed? Zura Bio Limited is listed on NASDAQ. Our directory also records these other listings: LS:A3D7LY; LSX:A3D7LY. What is the SEC CIK of Zura Bio? The SEC Central Index Key (CIK) for Zura Bio Limited is 1855644. Its filings are on SEC EDGAR. How many shares does Zura Bio have outstanding? 95,829,137 shares as of 2026-08-11, per the cover page of its 10-Q filed 2026-08-11. Which country or territory is Zura Bio listed under? Our directory records Zura Bio Limited under United States. What does Zura Bio do? Our directory classifies Zura Bio Limited as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Zura Bio? The ISIN recorded for Zura Bio Limited is KYG9TY5A1016. Does aibio.space cover Zura Bio? aibio.space lists Zura Bio Limited among 2,820 public biotech companies and publishes its news here as stories appear. Where is Zura Bio incorporated? SEC records list its state or country of incorporation as E9. Is Zura Bio profitable? Zura Bio Limited reported a net loss of $68.7 million for the fiscal year ended Dec 31, 2025, and used $64.8 million of cash in operations, per its annual report to the SEC. How much does Zura Bio spend on research and development? $42.1 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Zura Bio have? $187.7 million in cash at Sep 30, 2026, per its 10-Q. What is the latest Zura Bio (ZURA) stock news? Our latest story on Zura Bio, dated Jan 2, 2026: "Zura Bio to issue 8,657,402 shares and pay $7,325,000 to Athanor Capital, ends Stone Peach deals". Zura Bio will issue 8,657,402 Class A shares to Athanor Capital and pay it a $7,325,000 upfront fee within 30 days, ending its Stone Peach and BAFFX17 arrangements. An internal audit subcommittee review found no issue that affected previously filed financial statements, and the Athanor deal adds a $25,000,000 milestone payment. [Source](https://aibio.space/news/zura-bio-issue-8-657-402-shares-pay-7-325-000-athanor-capital-ends/). What is Zura Bio's latest stock offering or financing news? Our latest financing story, dated Jan 2, 2026: "Zura Bio to issue 8,657,402 shares and pay $7,325,000 to Athanor Capital, ends Stone Peach deals". Zura Bio will issue 8,657,402 Class A shares to Athanor Capital and pay it a $7,325,000 upfront fee within 30 days, ending its Stone Peach and BAFFX17 arrangements. An internal audit subcommittee review found no issue that affected previously filed financial statements, and the Athanor deal adds a $25,000,000 milestone payment. [Source](https://aibio.space/news/zura-bio-issue-8-657-402-shares-pay-7-325-000-athanor-capital-ends/). What is Zura Bio's market cap? We do not publish live share prices. In its annual report, Zura Bio Limited put the market value of shares held by non-affiliates (public float) at $59.0 million as of Jun 30, 2025. ## Investor discussion: Zura Bio Members talk about Zura Bio (ZURA). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Zura Bio, newest first. Each line links the filing it comes from. 1. 2026-03-19 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-K. [Source](https://www.sec.gov/Archives/edgar/data/1855644/000110465926032080/zura-20251231x10k.htm) 2. 2026-02-24 Financings Reported a financing. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1855644/000110465926019154/tm267012d1_424b5.htm) 3. 2026-01-02 Financings Reported an unregistered sale of its securities. SEC Form 8-K (Items 1.01,1.02,3.02,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1855644/000110465926000209/tm2531128d1_8k.htm) 4. 2025-07-01 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 5.02,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1855644/000110465925064427/tm2519325d1_ex99-1.htm) 5. 2025-06-04 Financings Reported a financing. SEC Form 8-K (Items 7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1855644/000110465925056205/tm2516644d1_ex99-1.htm) 6. 2025-04-17 Financings Reported an unregistered sale of its securities. SEC Form 8-K (Items 1.01,3.02,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1855644/000110465925036057/tm2512482d1_8k.htm) 7. 2025-03-25 Financings Reported a financing. SEC Form 8-K (Items 7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1855644/000110465925027815/tm2510350d1_ex99-1.htm) 8. 2025-01-13 Financings Reported a financing. SEC Form 8-K (Items 7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1855644/000110465925002833/tm252988d1_ex99-1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:ZURA on TradingView](https://www.tradingview.com/symbols/NASDAQ-ZURA/). ## SEC filings and registration - **SEC name**: Zura Bio Ltd - **CIK**: 1855644 - **Industry (SIC)**: Biological Products, (No Diagnostic Substances) (2836) - **US tickers**: ZURA (Nasdaq) - **State or country of incorporation**: E9 - **Fiscal year ends**: December 31 - **Filer category**:
Emerging growth company - **Business address**: 4225 EXECUTIVE SQUARE, LA JOLLA, CA, 92037 - **Phone**: 858-247-0520 - **Shares outstanding**: 95,829,137 as of 2026-08-11 (10-Q filed 2026-08-11) - **Former names**: JATT Acquisition Corp ### Recent filings (8-K and 6-K are the company's own announcements) - [8-K](https://www.sec.gov/Archives/edgar/data/1855644/000110465926097526/tm2623351d1_8k.htm) filed 2026-08-17 - [8-K](https://www.sec.gov/Archives/edgar/data/1855644/000185564426000007/zura-20260811.htm) filed 2026-08-11 - [10-Q](https://www.sec.gov/Archives/edgar/data/1855644/000185564426000006/zura-20260630.htm) filed 2026-08-11 - [8-K](https://www.sec.gov/Archives/edgar/data/1855644/000110465926079538/tm2619483d1_8k.htm) filed 2026-07-01 - [8-K](https://www.sec.gov/Archives/edgar/data/1855644/000110465926075826/tm2618327d1_8k.htm) filed 2026-06-18 - [8-K](https://www.sec.gov/Archives/edgar/data/1855644/000110465926065730/tm2615441d1_8k.htm) filed 2026-05-22 - [8-K](https://www.sec.gov/Archives/edgar/data/1855644/000162828026031701/zura-20260507.htm) filed 2026-05-07 - [10-Q](https://www.sec.gov/Archives/edgar/data/1855644/000162828026031696/zura-20260331.htm) filed 2026-05-07 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001855644), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Zura Bio Limited is a public biotech or pharmaceutical company listed on NASDAQ under the ticker ZURA, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Zura Bio Limited - **Ticker**: ZURA - **Listing**: NASDAQ - **Country or territory**: United States - **Business scope**: Biotechnology - **ISIN**: KYG9TY5A1016 - **Other listed symbols**: LS:A3D7LY; LSX:A3D7LY - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-ZURA/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/zura-bio/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Zura Bio (ZURA) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/zura-bio/